Ashlea Blackborough, a 34-year-old mother residing in Adelaide, Australia, was diagnosed with a rare subtype of ovarian clear cell carcinoma after initially dismissing recurring postpartum symptoms as common changes related to childbirth and breastfeeding, according to personal accounts published across multiple outlets including Newsweek.
Postpartum Symptoms and Dismissed Early Warning Signs
Following the birth of her son in July 2024, Blackborough began experiencing subtle physical shifts. According to her published accounts, these included frequent urination, mild back pain, occasional fevers, bloating, missed menstrual periods, and severe night sweats. Because she was breastfeeding and managing endometriosis, Blackborough attributed these signs to normal postpartum recovery and existing health conditions, a tendency she later noted often leads women to ignore underlying medical concerns.
Medical Escalation and Initial Mass Detection
The situation shifted in February 2025 when Blackborough developed a mild burning sensation during urination alongside a fever. When she attempted to purchase over-the-counter medication at a pharmacy, screening questions regarding recent fevers prevented the pharmacist from dispensing the treatment, prompting her to visit a general practitioner. A subsequent urine test and CT scan, ordered by her doctor, identified a 5-centimeter mass on her ovary. She was transferred to a local hospital’s emergency department, where nursing staff evaluated her CT results and diagnosed an ovarian abscess based on imaging alone, treating her with intravenous antibiotics before discharging her after symptoms subsided.
Pulmonary Embolism Diagnosis and Cancer Confirmation
By late September 2025, Blackborough experienced severe lethargy, shortness of breath, and discovered a visible lump in her abdomen. A return visit to her general practitioner in early October led to a transvaginal ultrasound, a second CT scan, and the discovery of pulmonary embolisms in her lungs, which accounted for her breathing difficulties. Following a biopsy procedure performed on Christmas Eve, Blackborough received a cancer diagnosis on New Year’s Eve 2025. Subsequent consultations with a gynecological surgeon confirmed a diagnosis of ovarian clear cell carcinoma.
Surgical Treatment and Chemotherapy
On January 27, 2026, Blackborough underwent a total hysterectomy. Pathology results one week later revealed a stage 1A hormone-positive cancer. Due to the aggressive nature of this rare subtype and limited clinical research regarding the specific diagnosis, medical teams recommended four rounds of chemotherapy following surgery. Blackborough opted against egg retrieval to prevent delaying the procedure, noting that hormone-positive cancer risks spreading with such delays.
Family Cancer History
Blackborough’s medical journey unfolded against a backdrop of familial cancer diagnoses. According to her accounts, her mother passed away at age 52 from bowel cancer when Blackborough was 20, her grandfather died from stomach cancer at 53, her eldest brother died from lung cancer at age 40 in 2025 just two weeks after diagnosis, and her father was subsequently diagnosed with a form of blood cancer.
Current Status and Advocacy
By September 2026, medical scans confirmed that Blackborough was officially cancer-free. She has since used social media platforms, including TikTok under the handle @ash_frances, to document her recovery and raise public awareness regarding ovarian cancer symptoms. Her primary message emphasizes that persistent physical changes should not be dismissed simply because they align with postpartum recovery.